Praxis Precision Medicines (PRAX) Change in Acquisitions & Divestments (2022 - 2025)
Praxis Precision Medicines has reported Change in Acquisitions & Divestments over the past 4 years, most recently at $61.9 million for Q4 2025.
- Quarterly results put Change in Acquisitions & Divestments at $61.9 million for Q4 2025, up 5.78% from a year ago — trailing twelve months through Dec 2025 was $312.7 million (up 154.19% YoY), and the annual figure for FY2025 was $312.7 million, up 154.19%.
- Change in Acquisitions & Divestments for Q4 2025 was $61.9 million at Praxis Precision Medicines, down from $125.5 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for PRAX hit a ceiling of $125.5 million in Q3 2025 and a floor of $3.0 million in Q2 2024.
- Median Change in Acquisitions & Divestments over the past 4 years was $58.5 million (2024), compared with a mean of $50.4 million.
- Biggest five-year swings in Change in Acquisitions & Divestments: plummeted 85.71% in 2023 and later surged 1876.57% in 2025.
- Praxis Precision Medicines' Change in Acquisitions & Divestments stood at $22.6 million in 2022, then crashed by 77.87% to $5.0 million in 2023, then soared by 1070.0% to $58.5 million in 2024, then increased by 5.78% to $61.9 million in 2025.
- The last three reported values for Change in Acquisitions & Divestments were $61.9 million (Q4 2025), $125.5 million (Q3 2025), and $59.3 million (Q2 2025) per Business Quant data.